Selective Endothelin-Receptor Antagonist to Reduce Blood Pressure - Selective Endothelin-Receptor Antagonist to Reduce Blood Pressure

Description:

The goal of the trial was to evaluate treatment with the selective endothelin-receptor antagonist darusentan in patients with treatment-resistant hypertension.